Dr. Cara A. Rosenbaum specializes in adult hematology/oncology--particularly in the treatment of multiple myeloma and lymphoma, and in the care of complications of multiple myeloma and the use of new therapies. She also performs bone marrow transplantation. Dr. Rosenbaum works closely with radiation oncologists, surgeons and interventional radiologists supporting an integrated approach to patient care. She has clinical expertise in non-malignant hematologic disorders, including clotting and bleeding disorders. Dr. Rosenbaum serves as principal investigator for a number of multiple myeloma and lymphoma clinical trials. She is an executive officer in the Cancer and Leukemia Group B, an oncology clinical research organization funded by the National Cancer Institute (NCI). In this role, Dr. Rosenbaum works closely with researchers at the national level and the NCI to develop cancer clinical trials for new therapies in lymphoma, myeloma, and leukemia, as well as bone marrow transplantation.

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Genentech
Abbvie
Bristol Myers Squibb
Janssen Oncology
GSK

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

 https://www.guidestar.org/profile/45-5354811